Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 6/20 | 0.49 |
| ▸ | NOS3 | P29474 | 5/20 | 0.49 |
| ▸ | NOS1 | P29475 | 5/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4842721 | 1.00 | NOS2 (0.49) | NOS2NOS3NOS1LMNAPOLB | |
| SCHEMBL28469490 | 0.90 | HSD11B1 (0.50) | NOS2NOS3NOS1LMNAPOLB | |
| SCHEMBL28456436 | 0.85 | GRIK1 (0.44) | LMNAKMT2AGRIK1GRIK2TP53 | |
| SCHEMBL3297767 | 0.84 | GSK3B (0.58) | LMNAGRIK1GRIK2CYP1A2MAPT | |
| SCHEMBL28875467 | 0.84 | GRIK1 (0.44) | LMNAMEN1KMT2AGRIK1GRIK2 | |
| SCHEMBL28811909 | 0.84 | GRIK1 (0.44) | LMNAMEN1KMT2AGRIK1GRIK2 | |
| SCHEMBL3292230 | 0.84 | GSK3B (0.58) | LMNAGRIK1GRIK2CYP1A2MAPT | |
| SCHEMBL28365008 | 0.84 | PTGS2 (0.50) | NOS2NOS3NOS1LMNAMEN1 | |
| SCHEMBL28311588 | 0.84 | PTGS2 (0.50) | NOS2NOS3NOS1LMNAMEN1 | |
| SCHEMBL15457003 | 0.84 | CYP19A1 (0.42) | LMNAPOLBMEN1KMT2AGRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111689887-B | Copper/iridium concerted catalysis asymmetric allylation/2-aza-Cope rearrangement reaction and application thereof | 武汉大学 | 2022-04-01 | — | — | CN | disclosed |
| CN-114105822-A | Pseudo C2Symmetrical chiral diallyl substituted compound and preparation method and application thereof | 武汉大学 | 2022-03-01 | — | — | CN | disclosed |
| CN-112279770-A | Chiral alpha-polysubstituted-alpha-fluorine-containing homoallylamine compound, and preparation method and application thereof | 武汉大学 | 2021-01-29 | — | — | CN | disclosed |
| CN-111689887-A | Copper/iridium concerted catalysis asymmetric allylation/2-aza-Cope rearrangement reaction and application thereof | 武汉大学 | 2020-09-22 | — | — | CN | disclosed |
| US-7342007-B2 | Lactams and uses thereof | ASTRAZENECA AB (SE) | 2008-03-11 | — | — | US | disclosed |
| US-7342007-B2 | Lactams and uses thereof | ASTRAZENECA AB (SE) | 2008-03-11 | — | — | US | disclosed |
| US-7342007-B2 | Lactams and uses thereof | ASTRAZENECA AB (SE) | 2008-03-11 | — | — | US | disclosed |
| US-20060183732-A1 | Novel lactams and uses thereof | ASTRAZENECA AB (SE) | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183732-A1 | Novel lactams and uses thereof | BACE1, BACE2, APP | NOS2 2607/4885NOS3 2840/4885NOS1 1882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.